Showing results (201-210 of 256) with videos related to

Sort By:
Pageof 26
Annals of the Rheumatic Diseases|July 24, 2007
Changes in bone mineral density in patients with recent onset, active rheumatoid arthritisM Güler-Yüksel, J Bijsterbosch, Y P M Goekoop-Ruiterman, et al.
Annals of the Rheumatic Diseases|December 1, 2010
A decrease in disease activity score (DAS) level is associated with a decrease in health assessment questionnaire (HAQ) score, independent of follow-up duration, during 5 years of tightly controlled treatment: results from the BeSt studyE van der Kooi, N B Klarenbeek, M Güler-Yüksel, et al.
Clinical Rheumatology|December 11, 2012
Risk of alanine transferase (ALT) elevation in patients with rheumatoid arthritis treated with methotrexate in a DAS-steered strategyL Dirven, N B Klarenbeek, M van den Broek, et al.
Annals of the Rheumatic Diseases|April 1, 2008
Changes in hand and generalised bone mineral density in patients with recent-onset rheumatoid arthritisM Güler-Yüksel, C F Allaart, Y P M Goekoop-Ruiterman, et al.
Annals of the Rheumatic Diseases|September 4, 2004
Outcomes of a multicentre randomised clinical trial of etanercept to treat ankylosing spondylitisA Calin, B A C Dijkmans, P Emery, et al.
Annals of the Rheumatic Diseases|April 26, 2007
Bone mineral density in patients with recently diagnosed, active rheumatoid arthritisM Güler-Yüksel, J Bijsterbosch, Y P M Goekoop-Ruiterman, et al.
Arthritis and Rheumatism|October 31, 2009
Does rheumatoid arthritis equal diabetes mellitus as an independent risk factor for cardiovascular disease? A prospective studyMike J L Peters, Vokko P van Halm, Alexandre E Voskuyl, et al.
Arthritis and Rheumatism|April 13, 2004
Slowing of bone loss in patients with rheumatoid arthritis by long-term high-intensity exercise: results of a randomized, controlled trialZuzana de Jong, Marten Munneke, Willem F Lems, et al.
Annals of the Rheumatic Diseases|January 16, 2007
Rheumatoid arthritis subtypes identified by genomic profiling of peripheral blood cells: assignment of a type I interferon signature in a subpopulation of patientsT C T M van der Pouw Kraan, C A Wijbrandts, L G M van Baarsen, et al.
Rheumatology (Oxford, England)|February 17, 2012
Sustained drug-free remission in rheumatoid arthritis after DAS-driven or non-DAS-driven therapy: a comparison of two cohort studiesDiane van der Woude, Karen Visser, Naomi B Klarenbeek, et al.
Pageof 26